Walgreens Boots Alliance, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $8.1 Billion | 1/9 | WBA $8.1B |
HITI $212.8M |
PETS $85.3M |
YI $62.0M |
RAD $36.9M |
MEDS $13.3M |
MDVL $2.9M |
LFLY $799,292 |
BIMI $0 |
Gross Margin | 17% | 6/9 | LFLY 89% |
MDVL 44% |
PETS 32% |
HITI 26% |
RAD 19% |
WBA 17% |
YI 6% |
BIMI 5% |
MEDS -4% |
Profit Margin | -1% | 3/9 | PETS 4% |
YI 0% |
WBA -1% |
HITI -3% |
LFLY -14% |
RAD -18% |
BIMI -100% |
MEDS -100% |
MDVL -100% |
EBITDA margin | -1% | 4/9 | PETS 4% |
HITI 3% |
YI 0% |
WBA -1% |
RAD -6% |
LFLY -7% |
BIMI -127% |
MDVL -1357% |
MEDS -7954% |
Quarterly Revenue | $39.5 Billion | 1/9 | WBA $39.5B |
RAD $5.6B |
YI $829.6M |
HITI $104.0M |
PETS $59.6M |
LFLY $8.4M |
BIMI $2.5M |
MDVL $405,000 |
MEDS $18,699 |
Quarterly Earnings | -$265.0 Million | 8/9 | PETS $2.3M |
LFLY -$1.1M |
MEDS -$1.8M |
BIMI -$3.1M |
HITI -$3.5M |
YI -$3.9M |
MDVL -$5.8M |
WBA -$265.0M |
RAD -$1.0B |
Quarterly Free Cash Flow | -$424.0 Million | 8/9 | YI $25.3M |
PETS $6.1M |
HITI $5.7M |
MEDS $4.2M |
LFLY -$345,000 |
BIMI -$2.1M |
MDVL -$5.3M |
WBA -$424.0M |
RAD -$949.9M |
Trailing 4 Quarters Revenue | $181.7 Billion | 1/9 | WBA $181.7B |
RAD $23.5B |
YI $3.4B |
HITI $392.7M |
PETS $306.8M |
LFLY $35.9M |
MDVL $23.8M |
BIMI $5.8M |
MEDS $4.4M |
Trailing 4 Quarters Earnings | -$8.8 Billion | 9/9 | WBA $39.5B |
RAD $5.6B |
YI $829.6M |
HITI $104.0M |
PETS $59.6M |
LFLY $8.4M |
BIMI $2.5M |
MDVL $405,000 |
MEDS $18,699 |
Quarterly Earnings Growth | -296% | 9/9 | PETS 3423% |
HITI 85% |
YI 82% |
MDVL 51% |
LFLY 48% |
BIMI 16% |
MEDS 7% |
RAD -208% |
WBA -296% |
Annual Earnings Growth | -1355% | 9/9 | HITI 89% |
PETS 65% |
LFLY 19% |
BIMI 13% |
MDVL 9% |
YI 4% |
RAD 1% |
MEDS -1080% |
WBA -1355% |
Quarterly Revenue Growth | 7% | 2/9 | HITI 9% |
WBA 7% |
YI -2% |
RAD -4% |
PETS -16% |
LFLY -21% |
BIMI -66% |
MDVL -96% |
MEDS -99% |
Annual Revenue Growth | -21% | 5/9 | YI 4% |
HITI 4% |
PETS 0% |
LFLY -16% |
WBA -21% |
MDVL -38% |
RAD -44% |
MEDS -51% |
BIMI -74% |
Cash On Hand | $859.0 Million | 1/9 | WBA $859.0M |
YI $122.6M |
RAD $92.9M |
PETS $52.0M |
HITI $35.5M |
LFLY $13.6M |
MEDS $7.7M |
BIMI $994,131 |
MDVL -$0 |
Short Term Debt | $2.8 Billion | 2/9 | RAD $4.2B |
WBA $2.8B |
YI $38.8M |
HITI $26.8M |
BIMI $2.0M |
PETS $446,000 |
MDVL $208,000 |
MEDS $32,607 |
LFLY -$0 |
Long Term Debt | $27.9 Billion | 1/9 | WBA $27.9B |
RAD $2.4B |
HITI $29.3M |
YI $14.7M |
BIMI $2.5M |
MDVL $2.1M |
PETS $768,000 |
MEDS $160,996 |
LFLY $0 |
PE | -1.00 | 1/9 | WBA -1.00 |
RAD -1.00 |
PETS -1.00 |
YI -1.00 |
BIMI -1.00 |
MEDS -1.00 |
MDVL -1.00 |
HITI -1.00 |
LFLY -1.00 |
PS | 0.04 | 6/9 | MEDS 3.00 |
HITI 0.72 |
PETS 0.28 |
MDVL 0.12 |
YI 0.08 |
WBA 0.04 |
LFLY 0.02 |
RAD 0.00 |
BIMI 0.00 |
PB | 0.72 | 5/9 | HITI 1.94 |
MEDS 1.13 |
PETS 0.88 |
YI 0.87 |
WBA 0.72 |
RAD 0.00 |
BIMI 0.00 |
MDVL 0.00 |
LFLY 0.00 |
PC | 9.42 | 1/9 | WBA 9.42 |
HITI 5.99 |
MEDS 1.72 |
PETS 1.64 |
YI 0.51 |
RAD 0.40 |
LFLY 0.06 |
BIMI 0.00 |
MDVL -1.00 |
Liabilities to Equity | 6.02 | 1/9 | WBA 6.02 |
BIMI 2.86 |
HITI 0.70 |
PETS 0.51 |
MDVL 0.30 |
MEDS 0.26 |
RAD 0.00 |
YI 0.00 |
LFLY 0.00 |
ROA | -0.11 | 4/9 | PETS -1% | HITI -1% | YI -2% | WBA -11% | RAD -23% | LFLY -27% | BIMI -40% | MDVL -100% | MEDS -172% |
ROE | -0.79 | 6/9 | RAD 83% |
LFLY 36% |
YI 9% |
PETS -1% |
HITI -2% |
WBA -79% |
BIMI -161% |
MDVL -200% |
MEDS -216% |
Current Ratio | 1.17 | 5/9 | MEDS 4.85 |
PETS 2.94 |
HITI 2.45 |
BIMI 1.41 |
WBA 1.17 |
YI 1.11 |
RAD 0.78 |
LFLY 0.58 |
MDVL 0.00 |
Quick Ratio | 0.02 | 7/9 | WBA -1.00 |
RAD -1.00 |
PETS -1.00 |
YI -1.00 |
BIMI -1.00 |
MEDS -1.00 |
MDVL -1.00 |
HITI -1.00 |
LFLY -1.00 |
Long Term Debt to Equity | 2.50 | 1/9 | WBA} 2.50 |
BIMI} 0.28 |
HITI} 0.27 |
MDVL} 0.09 |
PETS} 0.01 |
MEDS} 0.01 |
LFLY} 0.00 |
YI} -0.10 |
RAD} -1.21 |
Debt to Equity | 2.75 | 1/9 | WBA 2.75 |
HITI 0.52 |
BIMI 0.51 |
MDVL 0.10 |
MEDS 0.02 |
PETS 0.01 |
LFLY 0.00 |
YI -0.37 |
RAD -3.35 |
Burn Rate | 0.41 | 5/9 | LFLY 11.91 |
YI 10.94 |
MEDS 4.18 |
HITI 3.38 |
WBA 0.41 |
BIMI 0.27 |
RAD 0.04 |
MDVL 0.00 |
PETS -23.83 |
Cash to Cap | 0.11 | 7/9 | LFLY 16.97 |
RAD 2.52 |
YI 1.98 |
PETS 0.61 |
MEDS 0.58 |
HITI 0.17 |
WBA 0.11 |
MDVL 0.00 |
BIMI |
CCR | 1.60 | 2/9 | PETS 2.63 |
WBA 1.60 |
RAD 0.93 |
MDVL 0.92 |
BIMI 0.67 |
LFLY 0.30 |
HITI -1.63 |
MEDS -2.30 |
YI -6.42 |
EV to EBITDA | -160.75 | 9/9 | HITI} 43.01 |
LFLY} 23.34 |
PETS} 13.36 |
MDVL} -0.94 |
BIMI} -1.08 |
MEDS} -3.87 |
RAD} -17.98 |
YI} -65.52 |
WBA} -160.75 |
EV to Revenue | 0.21 | 6/9 | MEDS 1.30 |
BIMI 0.59 |
HITI 0.48 |
RAD 0.28 |
MDVL 0.22 |
WBA 0.21 |
PETS 0.11 |
YI -0.08 |
LFLY -0.36 |